A modified herpes virus boosted immune T cell infiltration in glioblastoma tumors and was associated with improved survival. Researchers from Mass General Brigham and Dana-Farber Cancer Institute report that a single dose of an oncolytic virus can help the immune system gain access to aggressive brain tumors. Oncolytic viruses are genetically engineered to infect and […]
Source link